Improvements in the cost and diagnostic accuracy of whole-exome and whole-genome sequencing are reshaping management of NICU patients. We explore benefits and barriers to use.
Vascular dyplasias are among the most-feared complications of the most common of the neurocutaneous syndromes. Here’s a super-focused recap of what is and isn’t known about them.
Better understanding of recurrence risk in pediatric arterial ischemic stroke is the focus of the ongoing VIPS II study. How and why arteriopathy swells that risk is a leading question.
Opportunities abound to improve pediatric neuroscience care through closer alignment with adult care. Here are three distinct examples.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
A 14-year-old presents with mild left hemiplegia, headache and T2 signal lesions in the deep white matter on MRI. If workup for demyelinating disease and infection is negative, what’s next?
Two-day symposium will feature lectures and break-out sessions on the latest evidence-based interventions and treatment techniques for pediatric conditions, including neurological disorders, orthopaedic conditions, autism and chronic pain.
High rates of neurodevelopmental disability are the one downside of improved survival among kids with congenital heart disease. Here’s why Cleveland Clinic created a Neurocardiac Clinic for these patients’ unique needs.
Cleveland Clinic Children’s Center for Pediatric Rheumatology has developed a nationally recognized comprehensive evaluation and treatment service for children with chronic vasculitis.